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The initial antibody repertoire is determined by multiple heavy and light chain 
variable region (V. and VL)  ~ gene segments and multiple joining gene segments 
(J~, Jx, JH, and D.). These gene segments can join in various combinations (1-8) 
and  complete V  gene products  can associate  in  different combinations.  As a 
result  of combinational joining  and  association,  the  size  of the  preimmune 
repertoire can in theory be as high as 10 7 different antibodies. This preimmune 
repertoire is further amplified by junctional diversity that arises by variation at 
the sites at  which gene segments join,  and by the addition  of nucleotides (N 
regions) during gene segment joining (9). Somatic mutation may also contribute 
to the preimmune repertoire, since mutation of the rearranged V gene of a pre- 
B cell line has been observed (10). Thus the number of different antibodies in 
an  individual  may approach  the number of preimmune B  lymphocytes. As a 
result, preimmune B lymphocytes of independent origin can be uniquely defined 
by the nucleotide sequence coding for their antibody V regions, particularly that 
of their heavy chain diversity region (DH) and N regions, since these are usually 
different even in antibodies of the same antigen specificity (11-15). On the other 
hand, sequence identity in these regions between lymphocytes of a single individ- 
ual would indicate that they are derived from a single preimmune B lymphocyte. 
The genotypes of individual lymphocytes are also unique at the unexpressed 
antibody loci. These silent alleles are often aberrantly rearranged gene segments 
(H-, ~-,  ~-), and hence can be as diverse as the productively rearranged genes 
(16).  In addition, DNA between the VK and JK loci of rearranged L chain genes 
is often retained. The nature of this upstream (U) DNA depends on which V~ 
and J, gene segments are joined, hence there is considerable variability in the 
nature  of this  upstream  DNA  (17).  As  these  types of rearrangements occur 
independently of the productive rearrangements, the context of H-, K-, and U 
DNA can also uniquely define a given lymphocyte. 
In this report we describe the V  region nucleotide sequence of a number of 
antihemagglutinin (anti-HA) antibodies generated from BALB/c  mice after a 
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secondary immunization with influenza virus A/PR/8/34  (PR8); we also identify 
the  unexpressed  V  gene rearrangements in these hybridomas.  We thereby can 
distinguish  examples originating from different lymphocyte clones and identify 
examples originating from the same lymphocyte clone, generated in vivo. Inter- 
clonal comparisons measure the contribution of combinatorial joining, junctional 
diversity,  and  combinatorial  association  (Vu,  V~)  to  diversity in  this  response. 
Intraclonal comparisons reveal the effects of a  high rate of somatic mutation at 
both expressed V. and VL genes. 
Materials and  Methods 
Antihemagglutinin Hybridomas.  Hybridomas from mouse H36 and H37 were derived 
by fusion of spleen cells with Sp2/0-Agl4. Mice were immunized intraperitoneally 24 d 
before fusion and again, intravenously, 3 d before fusion, using 1,000 hemagglutinating 
units of influenza virus A/PR/8/34 (H 1N 1) each time (18). 
Genomie Blot Hybridizations.  Hybridoma and  BALB/c liver DNA  were prepared as 
described by Perry et al. (19).  DNA were analyzed according to the method of Southern 
(20).  12  ~g  of  DNA  were  digested  with  Eco  RI  (Bethesda  Research  Laboratories, 
Gaithersberg, MD), electrophoresed through a 0.7% agarose gel, transferred to nitrocel- 
lulose (Schleicher and Schueil, Inc., Keene, NH), and hybridized with 32P-labeled probes 
at 65 ° C. The probes were plasmid clones pJ 11 (Fig. 5) (21), IVS (16), and PRI (17). pJ 11 
was used to identify H  chain rearrangements,  IVS to identify ~ chain rearrangements, 
and PRI was used to identify U rearrangements. After a final wash in 30 mM NaCI/3.0 
mM  sodium  citrate/0.1%  sodium  dodecyl sulfate (SDS)  for  1 h  at  65°C,  filters were 
exposed to x-ray film at -70°C. 
Isolation of  Recombinant Clones.  300 ~g of DNA from hybridoma H37-77 was digested 
with EcoRI. Digested DNA was loaded intotrough of a 0.7% agarose gel and electropho- 
resed.  Fractions of DNA were collected from a  second trough located  10 cm from the 
origin. Fractions containing the 2.8 kb rearrangedJx fragment (unpublished observation) 
were identified by Southern blot analysis using pJ 11 as a probe. DNA from the appropriate 
fraction was cloned into the EcoRI site of ~gtWES (22,  23).  Recombinant phage were 
identified by hybridization to pJ11 (24) and plaque purified. A restriction map was made 
by end labeling the EcoRI insert with a-[s~P]dATP with the Klenow fragment of PolI 
(Boehringer Mannheim Biochemicals, Indianapolis, IN), digested with various restriction 
endonucleases, and electrophoresed on 5% polyacrylamide gels. Appropriate fragments 
were cloned into M 13mp8 or M 13mp9 and sequenced by the dideoxy method (25). 
RNA Preparation.  RNA  was  prepared  from cells  grown  in  tissue  culture  or  from 
subcutaneous  tumors.  ~3-5  ×  l0  s  cells  were  grown  in  Dulbecco's modified  Eagle's 
medium (Gibco Laboratories, Grand Island, NY) with  10%  fetal calf serum. Cells were 
washed twice in phosphate-buffered saline and resuspended  in  10  mi of RSB solution 
(0.01  M NaCI, 3 mM MgCI2, 0.01  M Tris, pH 7.4). 50 #1 of Triton X-100 was added and 
the cells vortexed for 15 s. Cells were lysed by douncing and the nuclei and cell debris 
removed by centrifugation at 500 g for 10 min at 4°C. 2 ml of a solution containing 0.5 
M NaCI, 50/~M EDTA, 10 m Tris, pH 7.4, and 2.5% SDS were added to the supernatant 
and the supernatant extracted exhaustively with chloropane (chloroform/phenol, 1  : 1 vol/ 
vol, 0.05%  8-hydroxyquinoline, saturated with 0.01  M sodium acetate, 0.1  M NaCI and 
1 mM EDTA). The RNA was then ethanol precipitated. 
RNA was isolated from subcutaneous  tumors grown  in  BALB/c ×  NZB F1  mice as 
follows:  Tumor  tissue  was  rinsed  in  cold  0.9%  NaCi,  minced  into  small  pieces,  and 
transferred to  10  ml of cold 5% citric acid.  The tissue was homogenized until an even 
suspension was obtained, and the suspension was passed through eight layers of cheese- 
cloth.  The  cell  debris  was  removed  by  centrifugation  at  500  g  for  10  min  at  4°C. 
Supernatants  were  transferred  to  a  polycarbonate  tube  (Beckman  Instruments,  Inc., 
Fullerton, CA) and centrifuged at 25,000 rpm for 2 h at 4°C. The pellet was washed with 
0.01  M sodium acetate, pH 5, 0.05 M NaCI and dissolved in 25 ml of 0.01  M Tris, pH CLARKE  ET  AL.  689 
7.4,  0.1  M  NaCl,  1  mM  EDTA,  and  1.5%  SDS.  After  a  series  of three  chloropane 
extractions the RNA was ethanol precipitated. 
Poly(A)  ÷ RNA  was prepared as follows: RNA prepared from tissue  culture cells or 
subcutaneous tumors was removed from ethanol by centrifugation and resuspended in 2 
ml of 1 mM EDTA, 10 mM Tris, pH 7.6, 0.1% SDS. The RNA was heat-shocked at 68°C 
for 5 rain, cooled to room temperature, and NaCI was added to a final concentration of 
0.2 M. RNA solutions were passed through oligo(dT) Sepharose columns equilibrated in 
0.2  M NaCI,  1 mM EDTA,  10 mM Tris, pH 7.6, 0.1% SDS.  Poly(A)  ÷ RNA was eluted 
with  1 mM EDTA,  10  mM Tris, pH 7.6,  0.1%  SDS, ethanol-precipitated overnight at 
-20°C, resuspended in sterile H~O at 1 mg/ml, and stored at -70°C. 
RNA Sequencing.  RNA sequencing was carried out by extension of synthetic oligonu- 
cleotides homologous to ~ or "y constant regions. The K  primer (5'-TGGATGGTGGGAA- 
GATG-3'), the y-crossreactive primer (5'-GGGGCCAGTGGATAGAC-3'), specific for 
-y1, y2a, and "y2b H chain mRNA, and the y3 primer (5'AGGGACCAAGGGATAGAC- 
3') were made by the phosphotriester method (26). 
Dideoxy sequencing was carried out using a modification of the procedure reported by 
Air (27).  Each base reaction was done separately in a  5 #l volume containingl00  mM 
Tris, pH 8.3, 140 mM KCI, 10 mM MgCI2, 10 mM dithiothreitol (DTT). Cold dCTP was 
added  to each reaction  to a concentration  of 3  #M  and  a-[s~P]dCTP was added  to a 
concentration of 2.4 #M (670 Ci/mmol; New England Nuclear, Boston, MA). G-specific 
reactions contained 50 #M dATP, 50 uM dTTP, and 10 #M dGTP; A-specific reactions 
contained 50 #M dGTP, 50 #M dTTP, and  10 #M ATP; C-specific reactions contained 
50 #M dATP, dGTP, and dTTP; T-specific reactions contained 50 #M dATP, 50 #M 
dGTP,  and  10  #M  dTTP  (P-L  Biochemicais Inc.,  Milwaukee,  WI).  In addition,  each 
reaction contained 0.3 #M of the appropriate dideoxynucleotide (P-L Biochemicals Inc.). 
~2.5 #g (2.5 ~1) of poly(A)  + mRNA and 10 ng of primer (0.5 #!) were mixed, boiled for 
1 rain,  and quick-cooled on ice water.  2  #1  of RNasin (20-30  U/ml;  Promega Biotec, 
Madison, WI) and 1.5 #i of AMV reverse transcriptase (12-15 U/#I; Life Sciences, Inc., 
St.  Petersburg, FL) were added and the mixture aliquoted equally into each of the four 
nucleotide mixes. After 30 min at 37°C,  1 #l of 1 mM dATP, dGTP, dCTP, and dTTP 
was added to each and the reaction mixtures returned to 37°C for 10 min. The reactions 
were stopped by the addition of an equal volume of 98% formamide, 0.3% xylene cyanoi, 
0.3% bromophenoi blue. Samples were heat-shocked at 90°C and 3 gl were loaded on 80 
cm, 6% polyacrylamide gradient gels (28). The first 50 bases were resolved by a second 
sequence reaction containing a fourfold increase in the dideoxynucleotide concentration. 
Any uncertainties in the sequence ladder were resolved by carrying out a third sequencing 
reaction using a-sSS-dATP. For this method cold dCTP and a-[s~P]dCTP were eliminated 
and replaced with 0.05 #m dATP and 4 #M ~-sSS-dATP (500 Ci/mmol; New England 
Nuclear).  Deoxynucleotide and dideoxynucleotide concentrations were the same except 
that dATP was replaced with dCTP. 
A second method of obtaining H and L chain mRNA sequences, as described by Caton 
et al. (A. Caton, G. Brownlee,  L. Staudt,  and W. Gerhard, manuscript in preparation), 
was also used. H and L chain mRNA was completely extended using these oligonucleotides 
as primers. 40 ng of oligonucleotide were labeled with  10-20  U  polynucleotide kinase 
(Boehringer Mannheim Biochemicals) and  13 uM 3,-[3~P]dATP  (5,000 Ci/mmol; Amer- 
sham Corp., Arlington Heights, IL) in 100 mM Tris, pH 7.6, 10 mM MgCI2, 5 mM DTT, 
0.1  mM spermidine, and 0.1  mM EDTA. After 1 h at 37°C the reaction was stopped by 
boiling for 5 min and quick-cooled on ice water. ~10-40 #g ofpoly(A)  ÷ mRNA was added 
to the labeled primer, bringing the volume to 25.5 ul. Solutions were boiled for 1 min 
and quick-cooled in ice water. Reverse transcriptase buffer (12.5 t~l) containing 400 mM 
Tris, pH 8.3,560 mM KCI, 40 mM MgCI2 and 40 mM DTT, 5 ~,! of 5 mM dATP, dGTP, 
dCTP, and dTTP, 4 IA of RNasin (20 U/#I) and 3 ul of reverse transcriptase (12-15 U/ 
vl) were added to the RNA solution. After 2 h at 37°C the mRNA was digested with 25 
#1 RNase (0.5 mg/ml in 50 mM EDTA) at 37°C for 30 rain. The cDNA were extracted 
with phenol/chloroform (1:1 vol/vol, saturated with 10 mM Tris, pH 7.2, 10 mM EDTA, 
10 mM NaCl), ethanol-precipitated, and electrophoresed on a  5% polyacrylamide, 7  M 690  ANTIINFLUENZA  HEMAGGLUTININ  ANTIBODY  DIVERSITY 
urea gel for 3 h at 1,200 V. H and L chain cDNA transcripts  were identified  by exposure 
to film at room temperature. The cDNA were eluted from the appropriate gel slices in 2 
M ammonium acetate by shaking overnight at 37 °C. The cDNA were ethanol precipitated 
and  washed  extensively  before we  carried  out  Maxam  and  Gilbert  (29)  sequencing 
reactions. 
Results 
V,, and VL Sequences.  The complete V. nucleic acid sequences of 10 antibodies 
specific for the Sb antigenic site of HA are shown in Figs.  1, 2, and 3. These V. 
regions fall into four sets, each coded for by a  unique combination of V.,  D., 
and J. gene segments, as well as N region sequence. The VK regions of members 
of a set are also coded for by the same v.-J. gene segment combination (30 and 
Fig. 4).  The set that includes hybridomas H36-1, 4,  15, and  18 expresses a  V. 
gene of the 7183 family (Fig.  1). The 7183 V. family is one of seven families 
defined  in  the  mouse and  consists  of  10-12  V.  genes  (31).  This  V.  gene  is 
assigned to the  7183 family based on having >80%  sequence homology to the 
known members of this family, mRNA dot blot analysis supports this assignment, 
as mRNA isolated from these hybridomas hybridizes to a V. gene from the 7183 
family and not to V. genes from other families (data not shown). The V. gene 
from each member of this set has rearranged  to the DFL16.2 (7) and J.2 gene 
segments with identical V.-D. and D.-J.junctions.  There are two differences at 
the  D.-J.  boundary  (positions  311  and  313)  compared  with  the  germline 
DFL16.2 and J.2 sequences.  These substitutions may have been generated  by 
the  random  insertion  of bases during  D.-J.  rearrangement  or they may have 
been generated by somatic mutation after rearrangement. 
Hybridomas H36-5,  7, and  17 express a  V. gene of the S107 family (Fig.  2) 
(31, 32). This assignment is based on their having >80% sequence homology to 
the genes of this family. The expressed V. gene of this family hybridizes in an 
mRNA dot blot analysis with a gene from this family but not to genes of other 
V. families (data not shown). Of the four V. genes in the S107 family (32), the 
expressed gene in these hybridomas is most homologous (94-97%)  to V.-V11. 
Thus, the hybridomas of this set express mutants of the V 11 gene. This V. gene 
has rearranged to a D gene closest in homology to the DQ52 gene (6) and to the 
J.1  gene  segment  in  each  hybridoma.  In addition,  all  three  hybridomas  have 
identical V.-D. and D.-J. junctions.  The DQ52 germline gene segment consists 
of 10 nucleotides; however, in these examples only five nucleotides are spliced 
to the V and J  genes, and the second codon of D  is a hybrid codon formed by 
both the D and J  genes. 
The three hybridomas from mouse H37 can be assigned to two sets, based on 
both H  and L chain gene usage. One set includes hybridomas H37-77 and 63. 
Both have rearranged  the same V. gene (Fig.  3). This gene is 90% homologous 
to the V. gene rearranged  in hybridomas H36-1, 4,  15, and  18, and the cloned 
H37-77 V. gene,  when used as a probe in a  Southern  blot analysis of BALB/c 
DNA, hybridizes to restriction  fragments of sizes characteristic of the 7183 V. 
family (data not shown). It is unlikely that the expressed V. gene from hybrido- 
mas H36-1,  4,  15,  and  18 and  the expressed gene  in  H37-77 and  63 are  the 
same, since the size of the productive J. rearrangements in these hybridomas (as 
determined by Southern blot analyses) shows a difference in the location of the C
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TABLE  I 
H and L Chain Gene Rearrangements 
H +  H-  x  +  x-  Upstream 
-H36-5  2.9 kb  9.5 kb  3.8 kb 
H36-7  4.9 kb  2.4 kb  9.5 kb 
H36-17  4.9 kb  9.5 kb 
-H36-15  2.3 kb  5.0 kb  9.5 kb  3.7 kb  12.0 kb 
H36-18  2.3 kb  5.0 kb  9.5 kb  3,65 kb  12.0 kb 
H36-1  2.3 kb  5.0 kb  9.5 kb  3.7 kb  12.0 kb 
H36-4  2.1 kb  5.0 kb  9.5 kb  3.7 kb  12.0 kb 
-H37-63  2.8 kb  1.7 kb  5.6 kb  16.5 kb 
H37-77  2.8 kb  1.7 kb  5.6 kb  16.5 kb 
H37-85  2.4 kb  4.3 kb 
7.8 kb 
7.8 kb 
The Jn  rearrangements  (H  +,  H-), J,  rearrangements  (x+, x-),  and  upstream 
rearrangements  were detected by Southern  blot hybridization using the probes 
described (Materials and Methods). The H chain rearrangement for all hybri- 
domas were detected using EcoRI-digested hybridoma DNA. L chain rearrange- 
ments for the H36 hybridomas were detected using HindIII-digested hybridoma 
DNA (Huppi, manuscript in preparation),  whereas L chain rearrangements  for 
the H37 hybridomas were detected  using HindIII/BamHI-digested hybridoma 
DNA. All upstream  rearrangements were detected  after BamHI digestion of 
hybridoma DNA. Brackets indicate clonally related hybridomas. 
EcoRI  site  5'  of the  rearranged  V.  genes  (Table  I).  Therefore,  at  least  two 
members of the 7183  family are used in the response to the Sb site of HA. Both 
H37-77 and 63 have rearranged the expressed V. gene to the DFL16.2 andJ.3 
gene segments. 
H37-85 expresses a  VH gene with only 62-65%  homology to the V, genes of 
the S107  and 7183  VH families (Fig.  3).  It is closest in homology (96.5%) to the 
V.  gene  used  in  the  BALB/c  antiarsonate  response  (1210.7  V.)  (33).  This 
BALB/c antiArsonate V. gene hybridizes in a  Southern  blot analysis to a  set of 
restriction  fragments whose sizes are characteristic  of the  3660  VH family (31, 
33).  Thus, a  third  V, family can contribute  to the anti-HA (Sb) response.  This 
V.  gene  has  rearranged  to  a  D.  gene  with  ~40%  homology  to  any  known 
germline D, gene and to the J.2 gene segment. This D. segment may be coded 
for by an as yet unidentified germline DH gene or it may have been derived from 
a  known germline gene, such as DSP2 (7), that has been altered by the addition 
of nucleotides and somatic mutation. 
All seven H36 hybridoma antibodies express v~21C-J~2 L chains.  H37-77, 63, 
and  85 express V~ genes that are  97-99%  homologous to the  V~21C  germline 
gene sequence (34) (Fig. 4) and encode amino acids that distinguish V~21C from 
all other  V~21  subgroups (35,  36).  This gene  has rearranged  to J~4  in  H37-85 
and  to J~5  in  H37-77  and  63.  The  V~21C-J~5 junction  in  H37-77  and  63  is 
unusual  in  that at  least two and  possibly as many as five extra nucleotides are 
contributed  by the V~21C germline gene to create a  proline codon  not seen in 
any other V~2 IC sequence. 
Genetic  Rearrangements  at H  and  L  Chain  Loci.  The  nature  of rearranged 
DNA at both expressed and unexpressed loci is for the most part consistent with 
the idea that these  10 hybridomas originated from four different precursors (see 
Fig. 6).  A  previous study (30) suggested that four hybridomas from mouse H36 P
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FIGURE 5.  Southern blot hybridization of a JH probe, pJ 11, to DNA from the seven V,21  C- 
associated hybridomas  of mouse  H36,  BALB/c  liver  DNA, and  Sp2/0-Agl4  DNA  after 
digestion with EcoRl. All hybridomas share a 6.5 kb band that corresponds to an unrearranged 
JH locus, which may be derived from either the hybridoma or from contaminating host tissue. 
In addition, some hybridomas have a 5.6 kb rearrangement derived from the fusion partner 
Sp2/0-AgI4. H36-5 DNA shows a faint band at 2.9 kb. 
(H36-1, 4,  15, and  18) are derived from a  common lymphocyte precursor. This 
conclusion  was  based  on  shared  K  +,  K-,  and  U  rearrangements  (Table  I).  The 
remaining three  hybridomas from this  mouse (H36-5,  7, and  17) share certain 
V,  amino  acid  substitutions  (30)  but,  as  they  lack  K-,  and  U  rearrangements 
(Table I), their relationship to each other and to the other four H36 hybridomas 
was uncertain.  Of the three H37 hybridomas, H37-63 and H37-77 appear to be 
clonally related,  since they share a  K  +, K-, and two U  rearrangements (Table I). 
The  1.7  kb J, rearrangement is the expected size for the V~21C-J~5 joining and 
likely represents the K  + allele. The 5.6 kb band must therefore represent a shared 
K- allele. 
J,  gene  rearrangements  were  examined  for  all  10  hybridomas  (Fig.  5  and 
Table I).  Hybridomas H36-4,  1,  15,  and  18 each have two rearrangements.  All 
four share  a  5.0  kb  rearrangement,  three  share  a  2.3  kb  rearrangement,  and CLARKE  ET  AL.  697 
H36-4 has a  unique rearrangement of 2.1  kb.  The 5.0  kb rearrangement was 
cloned into the EcoRI site of hgtWES and used as a probe in a Southern blot of 
EcoRI-digested  BALB/c  liver  DNA.  This  DNA  clone hybridizes to  a  set  of 
restriction fragments characteristic of the DFL 16/SP2 families of D genes (data 
not shown), indicating that the 5.0 kb Jx rearrangement shared by H36-1, 4,  15, 
and 18 is a nonproductive D-J rearrangement, thus supporting the clonal relat- 
edness of these four hybridomas. The 2.3 kb rearrangement of H36-1,  15, and 
18 and the 2.1  kb rearrangement of H36-4  must therefore be the productive 
VH-DH-JH rearrangements. 
H36-17 and 5 each have just one hybridoma-specific  JH rearrangement (4.9 kb 
and 2.9 kb, respectively; Fig. 5 and Table I). Therefore, these must be productive 
rearrangements. H36-7 also has a  4.9 kb J. rearrangement. As this rearrange- 
ment is shared by H36-17, it is probably the productively rearranged VH in this 
hybridoma. In addition,  H36-7  has a  second rearrangement of 2.4  kb,  which 
must be nonproductive. The hybridomas of mouse H37  also share rearrange- 
ments at theJH locus (Table I). H37-77 and H37-63 each have a single rearrange- 
ment of 2.8 kb, while hybridoma H37-85 has a unique rearrangement of 2.4 kb. 
Since these are the only rearrangements in these hybridomas, each must repre- 
sent a productively rearranged V, gene. 
Several unique rearrangements among members of a set have been found. For 
instance, hybridomas H36-1,  15, and 18 share a 2.3 kb productive H chain gene 
rearrangement while H36-4 has a  2.1  kb productive rearrangement (Table I). 
The reason for the differences in size of these restriction fragments is not certain. 
Southern blot analysis of HindIII-digested DNA hybridized with pJ11  showed 
the same difference in size between the productive rearrangements, suggesting 
that it is not due to point mutation but more likely to either a deletion of DNA 
from  H36-4  or  an  insertion  of DNA  into  H36-1,  15,  and  18,  before  their 
divergence, A similar pattern exists among the second set of hybridomas from 
mouse H36. H36-7 and 17 share a 4.9 kb productive rearrangement, while H36- 
5 has a 2.9 kb productive rearrangement (Table I). This also may be explained 
by insertion, deletion, or point mutation. These three hybridomas also differ at 
their nonproductive loci. The lack of H- and K- rearrangements in two of these 
three hybridomas (Table I) can be explained by chromosome loss either before 
or after cell fusion. Alternatively, lymphocytes may continue to rearrange their 
H and L chain gene loci after productive rearrangements have occurred, thereby 
accounting for unshared rearrangements. 
Discussion 
The  secondary antibody  response  to  the  infleunza  HA  molecule is  highly 
diverse. It is estimated (18) that the BALB/c mouse has the potential of producing 
at least 500 different antibodies to any of the four major antigenic sites on the 
HA molecule. To understand the genetic basis of this diversity, we have analyzed 
the V region sequences of hybridomas secreting HA-specific antibodies, focusing 
on examples directed to the antigenic site Sb [HA (Sb)]. This survey of diversity 
includes analysis of the contribution of germline genes, combinatorial joining, 
and somatic mutation. Germline diversity is assessed by the V region differences 
found between members of different clones of lymphocytes; somatic mutation is 698  ANTIINFLUENZA  HEMAGGLUTININ  ANTIBODY  DIVERSITY 
assessed  by differences between members of the same clone of lymphocytes. 
Hybridomas from different individuals, i.e., mouse H36 or H37, are one source 
of examples of independent origin, while hybridomas from a single mouse may 
include examples of the same or different clonai origin. We are able to determine 
whether hybridomas from a single individual have originated from the same or 
different precursors on the basis of Vn region sequence. Because of the consid- 
erable flexibility in forming a complete Vn region gene, lymphocytes that have 
joined the same V,, DH, and J. gene segments and form identical junctions must 
be clonally related. Since these rearrangements are fixed, lymphocytes that differ 
in these respects must be of separate clonal origin. 
Interclonat  Diversity Among HA (Sb) Antibodies.  The  V.  and  V,  loci of the 
mouse are highly complex. Both loci are estimated to consist of a few hundred 
genes. These genes fall into families in which the average nucleic acid sequence 
homology between families is ~60% (31). The homology of genes within a family 
is much higher, averaging >85%. The size of families varies from ~40-50 genes 
(the V.-J558 family) to just one (such as VK167 [37] or Vxl and V~2 [38]). These 
germline complements of V genes provide an important source of diversity, one 
that is further amplified by the combinatorial joining of a  given V  gene with 
different D., J.,  or JK gene segments. The interclonal comparison of HA (Sb) 
antibodies reveals the extent of germline diversification. These antibodies have 
V.  regions drawn  from three different families (designated S107,  7183,  and 
3660 [31 ]). Different DH genes and JH genes are also represented within these Vr~ 
regions, and the junctions of these gene segments show both flexibility of  joining 
and apparent nucleotide additions (N sequences; Fig.  1, 2, and 3). Different V, 
gene products are also found among HA (Sb) antibodies. The V,21C subgroup, 
other V,21 subgroups, and at least one other V~ group (V~8) are represented (18 
and S. Clarke, W. Gerhard, and M. Weigert, manuscript in preparation). 
To assess the contribution of combinatorial joining, one must compare exam- 
ples that share a particular V gene segment. In this survey all examples express 
the product of a single V~ gene, VK21C. Combinatorial joining does add to the 
diversity of these antibodies; in this sample V,21C has joined to either J,-2, J,-4, 
or J~-5 (Fig.  6).  Combinatorial joining also diversifies V, regions. Primary and 
secondary HA (Sb) antibodies are frequently encoded by the Vn-V11 gene, which 
has been found to be joined to a variety of DH gene segments and two different 
J.  gene  segments (Fig.  2  and  Clarke,  manuscript  in  preparation).  A  further 
amplification of germline diversity arises from the combinatorial association of 
different V. and VL regions.  This  is  shown in  the comparison of the V,21C- 
associated HA (Sb) antibodies (Fig.  6). These VK21C L chains are paired with H 
chains from the three V. families described above. 
The effect of germline diversity on the specificity of these antibodies can be 
evaluated. These monoclonal antibodies have been tested for binding to mutants 
of the PR8 virus (18), each mutant differing from PR8 by a single amino acid 
substitution  (39).  This analysis provides a  reactivity pattern for each antibody 
from which one can infer the site of binding. Further, as these antibodies usually 
show reduced binding to different mutant viruses, these reactivity patterns also 
define the fine specificity of a  given antibody.  The extent to  which sequence 
differences affect specificity and fine specificity is obviously limited by the assay. CLARKE  ET  AL.  699 
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H36-18 
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H36-4 
H37-63 
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't  2  6 11 12 13'  VH  DH  JH  VK  J,< 
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H37-8~  IlllUl  nnunn  386o  (sPz)  2  v~2~c  4 
FIGURE 6.  Reactivity patterns of the  l0 V,21C-associated antibodies against a  panel of Sb 
mutant  PR8 viruses as reported by Staudt and  Gerhard  (18).  Binding that  is equal to that 
observed against  parental  virus PR8  is indicated by a  black box; partially reduced binding 
(50-75%), by a cross-hatched box; and strongly reduced binding (>75%, usually not detectable) 
by an open box.  In addition,  the gene segments used by each hybridoma are summarized. 
V11 denotes the use of a specific V. gene, whereas 7183 and 3660 denote the use of a member 
of the 7183 and 3660 V. families. H37-77 and 63 use a different member of the 7183 family 
than do H36-1, 4,  15 and  18, as indicated by 718Y, 
For example, antibodies with the same reactivity patterns might have distinguish- 
able specificities if tested against additional PR8  mutants. However, within the 
context of this panel of mutant PR8 viruses, it is apparent that the V~21C region 
plays a dominant role in antigen binding (Fig. 6). All of these antibodies bind to 
the Sb site in spite of major sequence differences in V. regions. In particular, 
H36-5  and H36-1  have equivalent reactivity patterns even though they differ 
vastly with regard to their Vn regions (Fig. 6). It seems likely that these antibodies 
were primarily selected for by immunization with PR8,  because of the contri- 
bution of V~21C  to their binding sites. This interpretation is supported by the 
pattern  of somatic  mutation  in  the V~21C  and  V,  genes coding for these  V 
regions. 
Somatic  Mutation  and Intraclonal  Diversity.  The  V,  region  sequences have 
identified sets of clonally related hybridomas from mice H36 and H37.  These 
clonal relationships are substantiated by shared nonproductive ~ and H  chain 
gene rearrangements and upstream K rearrangements (Table I).  Nevertheless, 
clonally related examples differ significantly in their Vn and V~ sequences (Figs. 
1-4).  By  definition  these  differences are  the  result  of somatic  mutation.  By 
comparing the sequences and reactivity patterns of hybridomas of a single clone, 
one can reach several conclusions concerning the nature of somatic mutation 
and can assess the effect of somatic mutation on fine specificity. 
The H36 hybridomas are members of two clones. Members of each clone have 
both shared mutations and unique mutations, because of sequential accumulation 
of mutations during clonal expansion. Two comprehensive genealogic trees that 
include all mutations in V. and VL coding regions are shown in Fig. 7. The clone 
that includes hybridomas H36-5,  7,  and  17  stems from a  precursor that rear- 
ranged the V.-V 11 and V,21C genes. These three hybridomas have accumulated 
20,  12, and  19  V.-coding region mutations and 9, 8, and  15 Vccoding region 
mutations (Fig. 7). The clone that includes hybridomas H36-1, 4,  15, and 18 is 
derived from a precursor that has rearranged a gene of the 7183 V. family and 700  ANTIINFLUENZA  HEMAGGLUTININ  ANTIBODY  DIVERSITY 
IV~ 7183 ;V~21C [ 
?/1  q/2 
/3 
?/12  1/3 
I VH- Vtl ;~2~C ] 
9/6 
312  4/I 
FIGURE 7.  Genealogic trees  of the two  lymphocyte  lineages generating  the seven  V,21C 
hybridomas from mouse H36.  Each lineage is constructed to require the fewest number of 
parallel  mutations.  Shared  mutations  occurred  early in  clonal expansion,  while the unique 
mutations occurred later in clonal expansion. One lineage (H36-1, 4, 15, and 18) derives from 
a  lymphocyte that  has rearranged a  VH gene of the 7183  family (V.-7183) and  the V,21C 
gene. The other lineage (H36-5,  7,  17) derives from a  lymphocyte that has rearranged  the 
Va-V11  and  V,21C  genes.  Numbers  alongside  branches  are  number  of VR  nucleic  acid 
substitutions from Figs.  1 and 2 over the number of V, nucleic acid coding region substitutions 
taken  from  Huppi  et  al.  (manuscript  in  preparation).  Question  marks  indicate  where  the 
number of VH substitutions is not known, since the V.-7183 germline sequence has not been 
determined. 
the V,21C gene. The total number of Vu mutations cannot be determined  for 
this clone in the absence of a germline sequence. However, we can compare the 
number  of V,  and  V,  mutations  by comparing  the  points  at  which  different 
progeny  in  this  clone  have  diverged.  The  number  of  mutations  that  have 
accumulated in VH and V, after divergence are nearly the same (Fig. 7). 
These observations suggest that the rate of somatic mutation must be similar 
at both V. and VL loci. To account for the extent of mutation at the V, locus of 
these cells, the mutation rate must be at least  10  -3 mutations per base pair per 
division (30). The rate of mutation can be estimated at the V. locus of hybridomas 
H36-5,  7,.and  17,  since  all  V.  mutations  for  these  are  known.  These  three 
hybridomas  have  accumulated  an  average  of  17  coding  region  mutations.  If 
these lymphocytes had divided every 18 h from the time of primary immunization 
to the time of fusion (24 d), then the rate of mutation at this V~ gene would be 
1.5 x  10  -3 per base pair per division. A major uncertainty in this estimate is the 
number of divisions during which mutation takes place. For example, mutations 
may accumulate before antigen selection, as suggested by studies on a pre-B cell 
line (10). Furthermore,  the precursors of these clones may have been stimulated 
by unknown antigens, thereby accumulating mutations before exposure to influ- 
enza virus. However, even if the number of divisions were doubled, the calculated 
rate of mutation would remain  high  (7.5 x  10-4), and would still  be five to six 
orders of magnitude  above the spontaneous mutation  rate  in eukaryotic DNA 
(4o). 
The  nature  and  distribution  of mutations  in  these  V  regions  suggests  that 
many of them are selected for by antigen.  Analysis of the noncoding mutations, 
i.e., silent and flanking sequence substitutions, has shown these to be randomly 
distributed in and around these V,21C genes (K. Huppi, S. Clarke, S. Litwin, L. CLARKE  ET  AL.  701 
Staudt, W. Gerhard, and M. Weigert, manuscript in preparation). If replacement 
mutations also occur at random in the V,21C gene, then selection of replacement 
mutations should influence both the ratio of replacement to silent mutations (R/ 
S) and the distribution of replacement mutations, since antigen-selected muta- 
tions must be replacement types and should be located predominantly in com- 
plementary-determining regions (CDR).  In addition, these features of antigen- 
selected mutations should be found in the V, genes and not in the V. genes, if 
the V,21C plays the dominant role in determination of the specificity of these 
antibodies,  as  argued  above.  Indeed,  the  V,21C  mutations  strongly indicate 
antigen selection: first, the R/S ratio is 10, and, second, 80% of the replacement 
mutations are in CDRs (Huppi, manuscript in preparation). In contrast, the V. 
regions of H36-5,  7,  17 (for which a germline sequence is known) have an R/S 
ratio of 1, and only 33%  of the replacement mutations are in CDRs.  Neither 
value is significantly different from that expected by a  random distribution of 
mutations. 
Surveys of V,21C-associated anti-HA (Sb) antibodies (Huppi,  manuscript in 
preparation) show that all cases have accumulated at least one CDR mutation, 
including H2-6C4,  a  rare example of an IgM antibody. Thus,  it appears that 
mutation of V,21C is required to create this specificity, an idea consistent with 
the recent observation  (Staudt and  Gerhard,  manuscript in preparation)  that 
V,21C antibodies are rare in the primary response to HA, but highly represented 
in  the secondary response.  That  somatic mutation can influence specificity is 
seen by a  comparison of the reactivity patterns between members of all three 
clones. The most striking differences are between hybridomas H37-77 and 63. 
H37-77  is unable to bind six of the nine Sb mutant virus, whereas H37-63 can 
bind all but one (Fig. 6).  If somatic mutants of V,21C were indeed exclusively 
selected for by antigen, then at the initial  stages of diversification, mutations 
should be predominantly replacement types in CDR. At later stages of diversifi- 
cation, additional CDR replacements may confer a selective advantage because 
of further modification of a combining site. However, it seems likely that most 
mutants with additional CDR amino acid substitutions would be at a  selective 
disadvantage once a well-fitting combining site is formed. Hence, at later stages 
of diversification  one  would  expect  a  preponderance  of flanking and  silent 
mutations. The order in which mutations have accumulated in these clones fits 
this  model.  The  shared  V,21C  mutations  presumed  to  have  occurred early 
during clonal expansion, have a high R/S ratio and are predominantly replace- 
ment mutations in  CDRs  (Huppi,  manuscript in preparation).  In contrast, the 
unique mutations in each hybridoma have a low R/S ratio and are predominantly 
flanking region or silent coding region mutations. 
Summary 
This study focuses on  10  BALB/c anti-influenza virus (A/PR/8/34)  hemag- 
glutinin antibodies that have light chains encoded by the same variable region K 
chain (V,) gene, V,21C.  A comparison of antibodies from lymphocytes of inde- 
pendent  origin  reveals  the  contribution  of germline  diversity  (combinatorial 
joining and association) to  this  response.  Although combinatorial joining and 702  ANTIINFLUENZA  HEMAGGLUTININ  ANTIBODY  DIVERSITY 
association contribute to sequence diversity, they appear to have little effect on 
the fine specificity of these antibodies. 
Somatic  mutation,  in  addition  to  contributing  to  the  sequence  diversity of 
these  antibodies,  creates  differences  in  their  fine  specificity.  The  extent  of 
mutation and its effect on fine specificity can be seen by comparing antibodies 
of lymphocytes from the same clone. These intracional comparisons also indicate 
that somatic mutation is an ongoing process occurring at a  high rate (estimated 
to be at least 10 -3 mutations per base pair per division) in the expressed V region 
heavy chain (V,) and V~ genes.  Furthermore, both the nature and distribution 
of these mutations suggest  that amino acid replacement mutations in the light 
but not the heavy chain are selected for by antigen. 
Received for publication  12 November 1984 and in revised form 28 December 1984. 
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